Literature DB >> 24354433

Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.

Chrysanthos Symeonidis1, Sofia Androudi, Tryfon Rotsos, Marilita M Moschos, Efimia Souliou, Stavros A Dimitrakos, Eudoxia Diza.   

Abstract

PURPOSE: To investigate the expression of chemokine CXCL-1 in the subretinal fluid (SRF) during rhegmatogenous retinal detachment (RRD) and identify potential correlations with number of quadrants involved and duration of the detachment. METHODS AND
RESULTS: Inclusion criteria were patients aged 18 years or older and primary RRD possibly complicated by proliferative vitreoretinopathy (PVR). CXCL-1 levels were measured in 36 SRF samples from 36 RRD patients. Mean CXCL-1 levels (102 ± 37 pg/mL) were significantly higher (p = 0.050) compared to controls. CXCL-1 levels correlated significantly with age (p = 0.001) and RRD duration (p = 0.002). Maximum CXCL-1 levels coincided with total RRD, 29- to 60-day duration and PVR grade C.
CONCLUSIONS: The findings of this study may contribute to increased understanding regarding the role of CXCL-1 during the onset and progression of the wound healing process in the context of RRD and PVR.

Entities:  

Keywords:  CXCL-1; GRO-α; proliferative vitreoretinopathy; rhegmatogenous retinal detachment; subretinal fluid

Mesh:

Substances:

Year:  2013        PMID: 24354433     DOI: 10.3109/09273948.2013.863942

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.

Authors:  C Symeonidis; S Androudi; I Georgalas; A Tzamalis; N Chalvatzis; T Rotsos; E Souliou; E Diza; S A Dimitrakos
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

2.  Oxidative stress enhanced the transforming growth factor-β2-induced epithelial-mesenchymal transition through chemokine ligand 1 on ARPE-19 cell.

Authors:  I-Hui Yang; Jong-Jer Lee; Pei-Chang Wu; Hsi-Kung Kuo; Yu-Hsia Kuo; Hsiu-Mei Huang
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.